Alright, here’s the pot news decoded: President Trump recently signed an executive order telling federal agencies to stop lumping marijuana in with heroin and LSD and move it out of Schedule I – the government’s “this has no medical value and is basically evil” category. Instead, marijuana is headed towards to Schedule III, with the feds admitting pot isn’t the devil.

What’s the difference between the two? As reported by the New York Post, a “Schedule III” drug is a substance “with a moderate to low potential for physical and psychological dependence.” A “Schedule I” drug has “a high potential for abuse and serves no legitimate medical purpose.”

What Trump’s Executive Order does not do: it doesn’t legalize marijuana nationwide, it doesn’t override state laws, and it doesn’t mean dispensaries get a gold star from the federal government. What it does do is order the feds to change things so that research is easier, banking is easier, brutal tax rules are eased, and Washington is officially dragged out of Reefer Madness mode.

Schedule III isn’t freedom though. It’s federal control with a lab coat. Once marijuana is officially a “medicine,” the FDA, DEA, and Big Pharma will get a bigger say. That opens the door to prescriptions, tighter rules, standardized products, and pharma companies muscling out small dispensaries that can’t afford the paperwork or compliance circus.

Bottom line: this isn’t a green light – it’s a reshuffle. Marijuana moves out of the government’s naughty corner, but straight into a tighter federal grip. Less “war on weed,” more “welcome to government oversight.” Progress? Maybe. Freedom? Not even close.